nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Hypotensive—Furosemide—dilated cardiomyopathy	0.036	0.138	CcSEcCtD
Phentolamine—Injection site pain—Furosemide—dilated cardiomyopathy	0.0161	0.0619	CcSEcCtD
Phentolamine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00871	0.0335	CcSEcCtD
Phentolamine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00786	0.0302	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00744	0.0286	CcSEcCtD
Phentolamine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00654	0.0251	CcSEcCtD
Phentolamine—Pruritus—Spironolactone—dilated cardiomyopathy	0.0061	0.0234	CcSEcCtD
Phentolamine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00603	0.0232	CcSEcCtD
Phentolamine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00599	0.023	CcSEcCtD
Phentolamine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0059	0.0227	CcSEcCtD
Phentolamine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.0059	0.0227	CcSEcCtD
Phentolamine—Dizziness—Spironolactone—dilated cardiomyopathy	0.0057	0.0219	CcSEcCtD
Phentolamine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00548	0.0211	CcSEcCtD
Phentolamine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00544	0.0209	CcSEcCtD
Phentolamine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00541	0.0208	CcSEcCtD
Phentolamine—Headache—Spironolactone—dilated cardiomyopathy	0.0054	0.0208	CcSEcCtD
Phentolamine—Nausea—Spironolactone—dilated cardiomyopathy	0.00512	0.0197	CcSEcCtD
Phentolamine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00504	0.0194	CcSEcCtD
Phentolamine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.0046	0.0177	CcSEcCtD
Phentolamine—Flushing—Lisinopril—dilated cardiomyopathy	0.0046	0.0177	CcSEcCtD
Phentolamine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00449	0.0173	CcSEcCtD
Phentolamine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00446	0.0172	CcSEcCtD
Phentolamine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00442	0.017	CcSEcCtD
Phentolamine—Hypotension—Furosemide—dilated cardiomyopathy	0.00438	0.0168	CcSEcCtD
Phentolamine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00421	0.0162	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00405	0.0156	CcSEcCtD
Phentolamine—Pain—Furosemide—dilated cardiomyopathy	0.00401	0.0154	CcSEcCtD
Phentolamine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00383	0.0147	CcSEcCtD
Phentolamine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00371	0.0142	CcSEcCtD
Phentolamine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00367	0.0141	CcSEcCtD
Phentolamine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00343	0.0132	CcSEcCtD
Phentolamine—Asthenia—Furosemide—dilated cardiomyopathy	0.00336	0.0129	CcSEcCtD
Phentolamine—Pruritus—Furosemide—dilated cardiomyopathy	0.00332	0.0128	CcSEcCtD
Phentolamine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00329	0.0126	CcSEcCtD
Phentolamine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00321	0.0123	CcSEcCtD
Phentolamine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00316	0.0121	CcSEcCtD
Phentolamine—Dizziness—Furosemide—dilated cardiomyopathy	0.0031	0.0119	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00304	0.0117	CcSEcCtD
Phentolamine—Pain—Lisinopril—dilated cardiomyopathy	0.00301	0.0116	CcSEcCtD
Phentolamine—Vomiting—Furosemide—dilated cardiomyopathy	0.00298	0.0115	CcSEcCtD
Phentolamine—Headache—Furosemide—dilated cardiomyopathy	0.00294	0.0113	CcSEcCtD
Phentolamine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00288	0.0111	CcSEcCtD
Phentolamine—Nausea—Furosemide—dilated cardiomyopathy	0.00279	0.0107	CcSEcCtD
Phentolamine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00278	0.0107	CcSEcCtD
Phentolamine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00252	0.0097	CcSEcCtD
Phentolamine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00249	0.00957	CcSEcCtD
Phentolamine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00241	0.00925	CcSEcCtD
Phentolamine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00233	0.00894	CcSEcCtD
Phentolamine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00224	0.0086	CcSEcCtD
Phentolamine—Headache—Lisinopril—dilated cardiomyopathy	0.0022	0.00847	CcSEcCtD
Phentolamine—Nausea—Lisinopril—dilated cardiomyopathy	0.00209	0.00803	CcSEcCtD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000899	0.00121	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00089	0.0012	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00089	0.0012	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000881	0.00119	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000862	0.00117	CbGpPWpGaD
Phentolamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000858	0.00116	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000854	0.00115	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000853	0.00115	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—SDHA—dilated cardiomyopathy	0.000838	0.00113	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000838	0.00113	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000835	0.00113	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000827	0.00112	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000827	0.00112	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000827	0.00112	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000812	0.0011	CbGpPWpGaD
Phentolamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000804	0.00109	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000801	0.00108	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000801	0.00108	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000795	0.00107	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000792	0.00107	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000783	0.00106	CbGpPWpGaD
Phentolamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000774	0.00105	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00077	0.00104	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000769	0.00104	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.000753	0.00102	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000745	0.00101	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000743	0.001	CbGpPWpGaD
Phentolamine—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000739	0.000999	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000731	0.000988	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000723	0.000978	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000712	0.000962	CbGpPWpGaD
Phentolamine—ADRA2B—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00071	0.00096	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—ITGB1—dilated cardiomyopathy	0.000687	0.000928	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000684	0.000925	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000682	0.000922	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000682	0.000922	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.000681	0.000921	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000667	0.000902	CbGpPWpGaD
Phentolamine—ADRA2C—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000663	0.000896	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000653	0.000883	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000649	0.000878	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—ITGB1—dilated cardiomyopathy	0.000641	0.000867	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000636	0.000859	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000634	0.000857	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000632	0.000855	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000619	0.000837	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000619	0.000837	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000616	0.000832	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000616	0.000832	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000614	0.00083	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000603	0.000815	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000593	0.000801	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00059	0.000797	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000588	0.000794	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—CD36—dilated cardiomyopathy	0.000586	0.000792	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000576	0.000778	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000575	0.000778	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000575	0.000778	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000573	0.000774	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000566	0.000765	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000566	0.000765	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000559	0.000756	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000559	0.000756	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000558	0.000754	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000555	0.00075	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—RAC1—dilated cardiomyopathy	0.000552	0.000746	CbGpPWpGaD
Phentolamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000551	0.000745	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000551	0.000745	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—CD36—dilated cardiomyopathy	0.000547	0.000739	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000542	0.000733	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000539	0.000728	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000535	0.000723	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000526	0.000711	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000525	0.000709	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000522	0.000706	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000522	0.000706	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000521	0.000704	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00052	0.000703	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000518	0.0007	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—RAC1—dilated cardiomyopathy	0.000516	0.000697	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000514	0.000695	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000514	0.000695	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00051	0.000689	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000504	0.000681	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000503	0.00068	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000503	0.00068	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000498	0.000673	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000486	0.000656	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000482	0.000651	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000478	0.000646	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000476	0.000644	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000474	0.00064	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00047	0.000636	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000468	0.000632	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000467	0.000632	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000467	0.000632	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000463	0.000626	CbGpPWpGaD
Phentolamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000458	0.000618	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000457	0.000617	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000457	0.000617	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000453	0.000612	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000452	0.000611	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000449	0.000607	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000447	0.000605	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	0.000444	0.000601	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000442	0.000598	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000435	0.000589	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000434	0.000587	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00043	0.000581	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000425	0.000574	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000424	0.000574	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000424	0.000574	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000421	0.000569	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00042	0.000567	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	0.000419	0.000566	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000413	0.000558	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000412	0.000557	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000411	0.000556	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000408	0.000551	CbGpPWpGaD
Phentolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000406	0.000549	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000402	0.000543	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000395	0.000534	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000394	0.000533	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000387	0.000523	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000386	0.000522	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000382	0.000516	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000381	0.000515	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000375	0.000507	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000372	0.000503	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000369	0.000499	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000367	0.000496	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—RAF1—dilated cardiomyopathy	0.000366	0.000495	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000366	0.000495	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000366	0.000495	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000359	0.000486	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000351	0.000475	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000351	0.000474	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000349	0.000471	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000348	0.00047	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000342	0.000462	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—RAF1—dilated cardiomyopathy	0.000342	0.000462	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000341	0.000461	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00034	0.00046	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000335	0.000453	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000333	0.00045	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000333	0.00045	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00033	0.000447	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00033	0.000447	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000329	0.000445	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000326	0.000441	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000326	0.00044	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000321	0.000433	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000317	0.000428	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000311	0.000421	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00031	0.000418	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000309	0.000417	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000309	0.000417	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000307	0.000415	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000306	0.000414	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000304	0.000411	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000304	0.000411	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000304	0.000411	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000303	0.000409	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000297	0.000402	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000296	0.0004	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000291	0.000394	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000287	0.000388	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000285	0.000385	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000283	0.000382	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000282	0.000382	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000282	0.000382	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000281	0.00038	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000278	0.000376	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000278	0.000376	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	0.000278	0.000375	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000273	0.00037	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000272	0.000368	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00027	0.000365	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00027	0.000365	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000267	0.000361	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000265	0.000358	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000259	0.00035	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000254	0.000343	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000253	0.000342	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000251	0.000339	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000251	0.000339	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000251	0.000339	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000247	0.000334	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000243	0.000328	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000241	0.000326	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00024	0.000325	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000237	0.000321	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000234	0.000316	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000233	0.000315	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000233	0.000314	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00023	0.00031	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000229	0.00031	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GPX1—dilated cardiomyopathy	0.000228	0.000308	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000226	0.000305	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000225	0.000304	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CD36—dilated cardiomyopathy	0.000222	0.0003	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000222	0.0003	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00021	0.000284	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000207	0.00028	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000207	0.00028	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000207	0.00028	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—AGT—dilated cardiomyopathy	0.0002	0.00027	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	0.000198	0.000268	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000197	0.000266	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000196	0.000265	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000193	0.000261	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000193	0.000261	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000193	0.000261	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00019	0.000257	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000187	0.000253	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	0.000185	0.00025	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000183	0.000247	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	0.00018	0.000244	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000179	0.000242	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000175	0.000236	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000172	0.000233	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000172	0.000232	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000169	0.000229	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—AGT—dilated cardiomyopathy	0.000167	0.000226	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000164	0.000222	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	0.000162	0.000219	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00016	0.000216	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000159	0.000215	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000157	0.000212	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000153	0.000207	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000146	0.000197	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000144	0.000195	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000142	0.000192	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000137	0.000186	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000136	0.000183	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000135	0.000182	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000132	0.000179	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000124	0.000168	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000118	0.000159	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000116	0.000157	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000114	0.000154	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000109	0.000148	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000101	0.000137	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	9.42e-05	0.000127	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	9.41e-05	0.000127	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	8.51e-05	0.000115	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—EGFR—dilated cardiomyopathy	7.95e-05	0.000107	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	7.82e-05	0.000106	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	6.95e-05	9.39e-05	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	6.46e-05	8.73e-05	CbGpPWpGaD
